Braxia Financial Statements From 2010 to 2024
| BRAXF Stock | USD 0 0 33.33% |
Check Braxia Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Braxia Scientific's main balance sheet or income statement drivers, such as , as well as many indicators such as . Braxia financial statements analysis is a perfect complement when working with Braxia Scientific Valuation or Volatility modules.
Braxia |
Braxia Scientific Corp Company Current Valuation Analysis
Braxia Scientific's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Braxia Scientific Current Valuation | 4.7 M |
Most of Braxia Scientific's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Braxia Scientific Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Braxia Scientific Corp has a Current Valuation of 4.7 M. This is 99.97% lower than that of the Healthcare sector and 99.9% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.97% higher than that of the company.
Braxia Scientific Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Braxia Scientific's current stock value. Our valuation model uses many indicators to compare Braxia Scientific value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Braxia Scientific competition to find correlations between indicators driving Braxia Scientific's intrinsic value. More Info.Braxia Scientific Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Braxia Scientific's earnings, one of the primary drivers of an investment's value.About Braxia Scientific Financial Statements
Braxia Scientific stakeholders use historical fundamental indicators, such as Braxia Scientific's revenue or net income, to determine how well the company is positioned to perform in the future. Although Braxia Scientific investors may analyze each financial statement separately, they are all interrelated. For example, changes in Braxia Scientific's assets and liabilities are reflected in the revenues and expenses on Braxia Scientific's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Braxia Scientific Corp. Please read more on our technical analysis and fundamental analysis pages.
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. Braxia Scientific Corp. is headquartered in Toronto, Ontario. Braxia Scientific operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Braxia Pink Sheet
Braxia Scientific financial ratios help investors to determine whether Braxia Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Braxia with respect to the benefits of owning Braxia Scientific security.